Drawing for ULTRAVIEW EXPRESS

USPTO serial 76341266

ULTRAVIEW EXPRESS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CASE, LEIGH CAROLINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ULTRAVIEW EXPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa A. Osman

LISA A OSMAN DORSEY & WHITNEY LLPREPUBLIC PLZ BLDG STE 4700370 SEVENTEENTH STDENVER, CO 80202-5647

Goods and services

ClassDescriptionStatusFirst use
009COMPUTER HARDWARE AND SOFTWARE FOR CLINICAL INFORMATION SYSTEMS AND PATIENT CARE DOCUMENTATION AND INFORMATION MANAGEMENT, NAMELY COMPUTERS; COMPUTER MONITORS; INTERFACE CARDS; ELECTRICAL CABLES; SOFTWARE FOR USE IN CONTROLLING AND MONITORING PATIENT PHYSIOLOGICAL PARAMETERS; COMPUTER HARDWARE; COMPUTER SOFTWARE FOR STORING, REVIEWING AND REPORTING PATIENT INFORMATION; CLINICAL INFORMATION SERVERS FOR STORING PATIENT INFORMATION; CENTRAL MONITORING STATIONS; LOCAL, REMOTE OR PORTABLE TERMINALS FOR PROVIDING HEALTHCARE PERSONNEL WITH ACCESS TO PATIENT INFORMATION; CHART PAPER; REMOTE DISPLAY MONITORS FOR DISPLAYING PATIENT INFORMATION; REMOTE MONITORING SYSTEMS COMPRISING A PORTABLE VISUAL DISPLAY UNIT FOR PATIENT MONITORING; COMPUTER INTERFACE DEVICES BETWEEN PERIPHERAL MEDICAL DEVICES AND PATIENT MONITORING SYSTEMS AND CLINICAL INFORMATION SYSTEMS; COMPUTER NETWORK AND COMMUNICATION NETWORK COMPONENTS RELATED TO PATIENT MONITORING SYSTEMS; AND COMPUTER SOFTWARE FOR USE IN THE MEDICAL FIELD, NAMELY, EMERGENCY CARE AND TREATMENT, ADULT/PEDIATRIC CRITICAL CARE, PERIOPERATIVE CARE, ECG MANAGEMENT, RESOURCE SCHEDULING, OBSTETRICS, NEONATAL CARE, AND POINT-OF-CARE RECORDSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 27, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 17, 2002DOCKASSIGNED TO EXAMINER—
Mar 11, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2002DOCKASSIGNED TO EXAMINER—
Feb 14, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance